Tuesday, January 5, 2010
ZOLL Emergency Defibrillator With CO Monitoring Gets FDA OK
Filed under: Emergency Medicine
, Military Medicine
The FDA has granted ZOLL Medical regulatory clearance to market the firm's new E Series defib that features Masimo's carbon monoxide detection technology. The ability to diagnose CO poisoning by distinguishing oxyhemoglobin from carboxyhemoglobin, and detecting drop in oxyhemoglobin saturation, is particularly relevant for paramedics when responding to fires where victims and firefighters may have potentially become poisoned.
Now with integrated Masimo® CO-Oximetry® carbon monoxide measurement, the E Series allows rescuers to easily and accurately diagnose CO poisoning with the simple push of a button. Recognition is the key to immediate on-scene treatment. With early detection, treatment for CO poisoning can begin immediately, which significantly reduces immediate and long-term health risks for both firefighters and the civilians whom they serve.ZOLL’s “Street Smart, Street Tough” E Series was designed by EMS professionals to meet the specific demands and extreme conditions that professional rescuers face every day. It features unique See-Thru CPR®, which filters out CPR artifact, allowing rescuers to see organized rhythms without interrupting chest compressions. Like all other ZOLL defibrillators, the E Series also provides Real CPR Help® which improves CPR quality by providing real-time feedback on the rate and depth of chest compressions. The E Series also offers wireless 12-lead transmission for improved STEMI (ST segment elevation myocardial infarction) management.
Press release: ZOLL RECEIVES FDA CLEARANCE TO MARKET E SERIES DEFIBRILLATORS WITH CARBON MONOXIDE MONITORING...
Zoll E Series Defibrillators...
Flashbacks: Easy Hemoglobin Monitoring Without Butterflies, Needles or Catheters ; Rad-57 Pulse CO-Oximetry™; ZOLL R Series Defibrillator with WiFi Given US Green Light; ZOLL R Series Defibrillator for Hospitals
(0)
examples: <b>Bold</b> <i>Italic</i>
